Literature DB >> 20036874

Comparison of methods for evaluating drug-drug interaction.

Liang Zhao1, Jessie L-S Au, M Guillaume Wientjes.   

Abstract

The goal of the present report is to compare several published methods of analyzing drug-drug interaction data. The compared methods are the curve-shift analysis, isobologram, combination index, and universal surface response analysis, and the comparison was based on analysis of published cytotoxicity data of combinations of two anti-folate agents. Major findings are as follows. The curve shift analysis enabled the inspection of the experimental data and visual evaluation of the approximate parallelism between the dose response curves. Isobologram analysis provided the range of concentration ratios where maximal synergy was obtained. The combination index analysis readily provided quantitative estimation of the extent of synergy or antagonism. The universal surface response method summarized drug-drug interaction in a single parameter, facilitating comparison of larger arrays of combinations. Only the curve shift analysis and the universal surface response method yielded a statistical estimate of differentiation between synergy, additivity, and antagonism. In summary, curve shift analysis, isobolograms, combination index analysis, and the universal response surface method are useful methods for analyzing drug-drug interaction, and provide complementary information.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20036874      PMCID: PMC2885905          DOI: 10.2741/e86

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  13 in total

1.  Synergy determination issues.

Authors:  Ting-Chao Chou
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 2.  Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.

Authors:  Meindert Danhof; Joost de Jongh; Elizabeth C M De Lange; Oscar Della Pasqua; Bart A Ploeger; Rob A Voskuyl
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Lecture on the Antagonism between the Actions of Active Substances.

Authors:  T R Fraser
Journal:  Br Med J       Date:  1872-11-02

4.  The search for cytotoxic synergy between anticancer agents: a case of Dorothy and the ruby slippers?

Authors:  W R Greco; H Faessel; L Levasseur
Journal:  J Natl Cancer Inst       Date:  1996-06-05       Impact factor: 13.506

Review 5.  What is synergy?

Authors:  M C Berenbaum
Journal:  Pharmacol Rev       Date:  1989-06       Impact factor: 25.468

Review 6.  The search for synergy: a critical review from a response surface perspective.

Authors:  W R Greco; G Bravo; J C Parsons
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

7.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

8.  The expected effect of a combination of agents: the general solution.

Authors:  M C Berenbaum
Journal:  J Theor Biol       Date:  1985-06-07       Impact factor: 2.691

9.  Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses.

Authors:  Liang Zhao; M Guillaume Wientjes; Jessie L-S Au
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

10.  A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example.

Authors:  Donald B White; Harry K Slocum; Yseult Brun; Carol Wrzosek; William R Greco
Journal:  Curr Drug Metab       Date:  2003-10       Impact factor: 3.731

View more
  69 in total

1.  Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.

Authors:  Yanmei Hu; Jiantao Zhang; Rami Ghassan Musharrafieh; Chunlong Ma; Raymond Hau; Jun Wang
Journal:  Antiviral Res       Date:  2017-08-02       Impact factor: 5.970

2.  ANOVA and the analysis of drug combination experiments.

Authors:  John C Ashton
Journal:  Nat Methods       Date:  2015-12       Impact factor: 28.547

3.  Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.

Authors:  Emilie A G Molins; William J Jusko
Journal:  AAPS J       Date:  2018-06-27       Impact factor: 4.009

Review 4.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

5.  An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer.

Authors:  Monjri M Shah; Zachary C Dobbin; Somaira Nowsheen; Monica Wielgos; Ashwini A Katre; Ronald D Alvarez; Panagiotis A Konstantinopoulos; Eddy S Yang; Charles N Landen
Journal:  Gynecol Oncol       Date:  2014-05-15       Impact factor: 5.482

6.  Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.

Authors:  M Allison Wolf; Pier Paolo Claudio
Journal:  Nutr Cancer       Date:  2014-01-21       Impact factor: 2.900

7.  Interactions of everolimus and sorafenib in pancreatic cancer cells.

Authors:  Dipti K Pawaskar; Robert M Straubinger; Gerald J Fetterly; Wen W Ma; William J Jusko
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

Review 8.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

9.  Evaluation of the Combination of Azithromycin and Naphthoquine in Animal Malaria Models.

Authors:  Zhu-Chun Bei; Guo-Fu Li; Jing-Hua Zhao; Min Zhang; Xiao-Guang Ji; Jing-Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

10.  Enhanced antitumor effect of alectinib in combination with cyclin-dependent kinase 4/6 inhibitor against RET-fusion-positive non-small cell lung cancer cells.

Authors:  Takaaki Fujimura; Koh Furugaki; Naoki Harada; Yasushi Yoshimura
Journal:  Cancer Biol Ther       Date:  2020-08-23       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.